in this regard and point to a group of peptide growth factors as well as by some drugs and toxic particles. The elaboration that may be largely responsible for the development of of certain peptide growth factors is thought to be key to the IPF (4, 6) . For example, asbestos exposure induces rapid development of this disease process. In addition, genetic susexpression of platelet-derived growth factor (PDGF) iso- Pursuant to this "growth factor hypothesis," we are using to TGF-␤ 1 expression at three concentrations of virus. These selected mouse strains in attempting to understand the findings suggest that certain sequences in a gene or a cluster of genes in the 129 mouse strain impart a phenotype in which pathogenesis of IPF as well as the genetic basis for "susceptithere is a delay in, or protection from, the development of lung bility" in a given animal's response to a fibrogenic agent.
Thus, in any population of mice exposed to fibrogenic agents such as asbestos or TGF-␤, there is a range in the degree Various mouse strains are commonly used to provide modof response, just as has been observed in populations of els of human lung disease. Among these are interstitial lung occupationally exposed workers (16) . To sort out the basis disease induced by inhaled particles (1, 2) or by viral vectors of this susceptibility is enormously important from a public that transduce expression of peptide growth factors (3, 4) .
health standpoint, and it will be a difficult task because of These studies are performed in attempts to understand the the many thousands of genes that could be involved. We molecular mechanisms that mediate the development of are attempting to take advantage of observations made in idiopathic pulmonary fibrosis (IPF). This disease process a strain of inbred mice known as the 129J. This strain has has multiple etiologies and afflicts millions of individuals been used for decades in skin-painting experiments (17) worldwide (5) . It has been difficult to sort out the mechaand as a source of embryonic stem cells (18) . In the skin nisms of disease because so many mediators are elaborated painting experiments, the 129 mice exhibited a reduced as the process progresses. The animal models are invaluable dermal scarring response. In our laboratory, we showed that these mice develop a reduced fibroproliferative response to inhaled asbestos, accompanied by reduced expression of (pfu) using the method described (21) except 911 cells (23) were here, we crossed 129 and C57 mice to produce an F1 generaused instead of 293 cells and plaques were counted on tion that was then backcrossed to either the 129 or C57 founders. If specific sequence changes in a gene or cluster of genes are controlling this protection from asbestos, it should separate out into a predicted number of offspring Viral Instillation that results from the F1 ϫ 129 backcross. We show here that Six-to eight-week-old male, pathogen-free 129 or C57BL/6 mice 26% of these asbestos-exposed offspring failed to develop weighing 20-25 g were purchased from Jackson Laboratories. The asbestos-induced lung lesions, whereas only one out of 21 animals were housed in a temperature-and light-controlled room (4.7%) mice from the F1 ϫ C57 cross had no disease.
with free access to food and water. Mice were anaesthetized intraIn addition, inasmuch as TGF-␤ (as discussed above) is peritoneally with 0.8 ml/kg of body weight of a solution of Ketaset (90.9 mg/ml ketamine and 9.1 mg/ml xylazine; Fort Dodge Laboralikely to play a major role in the development of IPF regardtories Inc, Fort Dodge, IA) before making a midline incision of less of the inducing agent, we asked if differences in disease ‫ق‬ 1 cm in the neck and visualizing the trachea by carefully moving development could be identified in the two mouse strains the musculature. Known concentrations of the virus in 50 l of consequent to transduction of TGF-␤ overexpression by an sterile PBS was instilled intratracheally using a 50-l Hamilton adenovirus vector. We show here that, again, this time even syringe (Hamilton Co., Reno, NV) attached to a 33-gauge needle.
with direct application of the growth factor to the lung mouse strain early in the disease process at three concentrations of virus.
Lung Fixation and Histologic Evaluation

Materials and Methods
Anaesthetized mice (n ϭ 3-5 per group) were instilled with 5 ϫ 8 pfu of AdVMG3 (AV) in 50 l intratracheally as described Eight-to twelve-week-old C57BL/6 or 129 mice (Jackson Laboraabove. At 4, 7, 14, and 28 d after treatment, the animals were tories, Bar Harbor, ME) were exposed to an aerosol of chrysotile killed by intraperitoneal injection of 0.9 ml/kg of body weight of asbestos as described earlier (19) . The asbestos exposures were Ketaset, followed by exsanguination through the renal artery. performed in two separate experiments. In one experiment, the After exposing the chest cavity, the right main bronchus was su-C57BL/6, 129, or F1 (C57BL/6 ϫ 129) mice received a single exposure of 16.3 mg/m 3 asbestos for 5 h. In a second experiment tured at the base of the main stem and the right lung was clipped the (F1 ϫ 129), (F1 x C57BL/6), or C57BL/6 mice were exposed off, snap-frozen in liquid nitrogen, and stored at -70ЊC for mRNA to asbestos for 5 h each day for two consecutive days (fiber concenanalysis. The left lung was perfused with 10% neutral buffered trations, 12.8 and 17.5 mg/m in fresh 10% neutral buffered formalin for 16-20 h at 4ЊC before were maintained in room air as controls. The animals were killed processing and embedding. Sections (4 m) from each sample were 48 h after exposure by an intraperitoneal injection of 0.9 ml/kg of stained with Hematoxylin and Eosin (H&E) for histopathologic body weight of Ketaset followed by exsanguination through the evaluation. renal artery. Lung fixation and histologic evaluation were perThe same procedure was followed for histopathologic evaluaformed as described below.
Asbestos Exposure
tion of lung tissue from mice exposed to asbestos and killed 48 h after exposure. Severity of disease pathology was quantified by microscopic
Recombinant Adenovirus Vectors: Propagation
evaluation of each H&E section in a blinded method as described and Purification previously (7) (8) (9) (10) 19) . Two sections were examined from each animal and the severity scores assigned were as follows: 0 (normal); Replication-deficient, human adenovirus type-5 genome-based re-1 (slight peribronchiolar and/or perivascular inflammation); 2 combinant virus expressing the biologically active porcine TGF-␤ 1 (spread of inflammation to parenchyma); 3 (widespread inflamma-(AdV TGF-␤ 1 223/225 ) was provided by Dr. Jack Gauldie (McMaster tion and fibrogenesis); 4 (severe diffuse inflammation and fibroUniversity, Hamilton, ON, Canada). Replication-deficient, human genesis). adenovirus type-5 genome-based recombinant viruses carrying either an unrelated DNA sequence in place of the coding region for TGF-␤ 1 (AdVMG3) was constructed in the laboratory of Dr. David Curiel (University of Alabama at Birmingham, Birmingham, AL)
Collection of Bronchoalveolar Lavage
and kindly provided by Dr. Deborah Sullivan (Tulane University Anaesthetized mice (n ϭ 3-5 per group) were instilled with 5 ϫ Health Sciences Center, New Orleans, LA). 10 7 or 10 8 pfu of AdTGF␤ 1 223/225 (AdVTGF␤ 1 ) or AdVMG3 (AV) The methods for propagation and purification of the recombiin 50 l of sterile PBS as described above. At 4, 7, 14, and 28 d nant adenoviruses were as previously described (21, 22) . The viafter treatment, bronchoalveolar lavage (BAL) samples were colruses were purified by two rounds of CsCl-gradient centrifugation lected by instillation of five 0.8-ml aliquots of cold lavage buffer and the CsCl was removed by chromatography of the virus suspen-(PBS ϩ 0.4 mM EDTA), one aliquot at a time, using a 1-ml syringe sion using Econo-Pac 10 DG desalting columns (Bio-Rad Laboraattached to a 20-gauge intravenous catheter (Johnson and Johnson tories, Hercules, CA). Fractions of virus in 10% glycerol in phosMedical, Arlington, TX) inserted into the trachea. The first aliquot phate-buffered saline (PBS) were pooled. Total particles of virus of lavage buffer recovered was kept separate and the rest were were measured by a spectrophotometric value at 260 nm and infectious particles were assessed by measuring plaque-forming units pooled. All volumes of recovered lavage buffer were recorded.
reported as a percentage of total cells counted for each
Cytologic Evaluation of Inflammatory Cell Accumulation
location.
in the Lung
All BAL samples collected were centrifuged at 4,000 rpm for 5 min. at 4ЊC to separate the cells from the supernatant. The superna-
␤-Galactosidase Expression in C57BL/6 and 129
tant from the first lavage was stored at -70ЊC in 0.2-ml aliquots
Mouse Strains
for TGF-␤ 1 protein analysis (see below). The cells from all five aliquots of BAL fluid were pooled by resuspension in 0.4 ml of To determine whether or not there were differences in degree of lavage buffer, and total cell numbers in the BAL were determined expression of a common gene, 5 ϫ 10 8 pfu of an adenoviral vector using a hematocytometer. Cells (5 ϫ 10 4 from each sample) were carrying the coding region for Escherichia coli ␤-galactosidase transferred onto glass slides using a Cytospin centrifuge (Shandon, (lacZ) gene (rAdVCMVLacZ) were instilled intratracheally into Pittsburgh, PA). Cell smears thus prepared were dried briefly and C57BL/6 and 129 mice (n ϭ 3-7) as described above. The animals stained with Diff Quick (Baxter, McGaw Park, IL) for differential were killed after 7 d of treatment and the lungs were perfused cell staining. Differential cell counts were made by counting 500 with 5 ml of saline injected through the pulmonary artery to clear cells/prep in random fields on a light microscope at ϫ400 magnifithe lungs of all blood. The lung tissue was homogenized in 0.5 ml cation.
of reporter lysis buffer (Promega) using a tissue homogenizer. The homogenate was centrifuged and the supernatant was used to measure the ␤-galactosidase activity using a commercial ␤-galactosidase enzyme assay system (Promega) according to the manufac- , and 10 9 pfu) were assessed at 7 d after exposure (Figure 3 ). The 10 8 and 10 9 doses were evaluated by histopathology at 7 and 14 d (Figures 3 and 4) . Degree of disease induced by the 10 8 pfu dose was quantified at 4-28 d after treatment ( Figure 5 ), and the 5 ϫ 10 7 dose was quantified at Day 7 only. The histopathologic findings were the same, as we reported previously in a study to establish responses to a broad dose range in C57 mice (26). At both the 10 8 and 10
9 pfu doses, the histopathology appeared worse in the C57 than in the 129 mice at 7 d after treatment. Because the 10 9 pfu dose was lethal for most of the 129 mice, quantitation was performed with the 
BrdU Incorporation
The degree of lung cell proliferation in the two mouse strains was assessed by quantitation of BrdU incorporation ( Figure 6 ). At 7 and 14 d after treatment, the percentages of BrdU-positive cells were just as predicted by the histopathology, with the C57 mice exhibiting significantly more proliferation at every anatomic region studied at 7 d, but by 14 d, the 129 mice appeared to have more disease (Figure 6 ). The airway epithelium at both time points and in both strains exhibited a reduced proliferative response compared with the interstitium, probably due to the presence of abundant TGF-␤ 1 as we reported previously in separate studies (15, 26) .
Quantitation of TGF-␤ Protein
Quantitation of active and latent TGF-␤ 1 in lavaged fluids showed significantly more protein at Day 4 from the lavage of C57 mice than from the 129 animals (Figure 7 ). At the 7-d time point, there is significantly more TGF-␤ 1 than in Figure 1 . Histopathology of asbestos-exposed lung tissue in the control mice, but differences between the two strains C57BL/6 and 129 mice: 48 h after exposure, C57BL/6 or 129 mouse lungs were fixed and sections stained with H&E for assessment of fail to reach statistical significance (Figure 7 ). We have shown that two fibrogenic agents, asbestos fibers cell types, the number of macrophages was consistently delivered by an aerosol generator and TGF-␤ 1 transduced higher in 129 mice through Days 4-28, the difference being statistically significant only on Day 14, when the disease by an adenovirus vector, cause interstitial inflammation and fibrogenesis in the lungs of two mouse strains. The 129 strain appeared to develop less asbestos-induced disease through the 1-mo period studied in our earlier work (19) , and here as well, at the 48-h postexposure time point selected for a closer, quantitative comparison. When the inbred 129 mice were crossed with the C57 strain, an F1 generation was produced that exhibited a broad range of histopathologic responses to asbestos exposure ( Figure 2) . If there were a gene or closely related cluster of genes that is responsible for this apparent protected phenotype, backcrossing the F1 mice to the 129 inbred animals should separate out a subset of mice with the protected phenotype. This was the case inasmuch as 26% of these offspring did not develop asbestos-induced lung lesions (Figure 2 ). lung fibroblasts from the 129 strain respond less to growth Figure 6 . BrdU incorporation in AdVTGF␤ 1 -instilled C57BL/6 and 129 mice. At 7 and 14 d after treatment, BrdU-positive cells were quantitated by immunohistochemical staining and visualization using light microscopy at ϫ400 magnification. C57 mice exhibited significantly more proliferation at every anatomic region studied at 7 d. By 14 d, the 129 mice appeared to have more disease. The airway epithelium at both time points and in both strains exhibited a reduced proliferative response compared with the interstitium. All mice that received the control virus had mean % values between 0.00 and 0.24. AE, alveolar epithelium; AI, alveolar interstitium; IF, interstitial foci; CA, cross-section of airway epithelium; CI, cross-section of airway interstitium; IP, involved parenchyma; UP, uninvolved parenchyma. *P Ͻ 0.05 (comparison between the two strains); M ϭ marginally significant. factors such as TNF-␣, PDGF, and TGF-␤; the cells grow found at Day 4 ( Figure 7 ). This would explain the worse disease in these C57 mice at a later time point (Day 7) more slowly and produce less collagen in vitro than compaafter treatment ( Figure 5 ). How early expression of TGF-␤ 1 rable cells from C57 mice, and these cells also appear to mediates development of a fibroproliferative process through exhibit reduced expression of the RNA and protein that the subsequent 2 wk has yet to be established, although it codes for the PDGF-␣ receptor (20, 27) .
is clear that TGF-␤ 1 is a potent chemotactic factor with a In the work presented here, we have asked if the differenvariety of effects on other cell types (29-31). tial response to growth factors is apparent in vivo in the Active TGF-␤ 1 has been used in several laboratories 129 and C57 inbred mouse strains. The comparison using to produce fibroproliferative lung disease (4). The active TGF-␤ was initiated for several reasons: (i ) TGF-␤ is the TGF-␤ 1 apparently induces expression of large amounts most potent inducer of extracellular matrix components yet described (29, 30) ; (ii) TGF-␤ is expressed at sites of initial lung injury in our asbestos model (9, 28) , other models of IPF appear to involve TGF-␤ to varying degrees (3, 4) , and TGF-␤ has been identified in association with human IPF (29) ; and (iii) we have shown that an adenovirus vector transducing expression of active TGF-␤ causes dose-dependent interstitial fibrogenesis in mice (26), including fibrogenic-resistant TNF-␣-receptor knockout mice (15) .
TGF-␤ overexpression through the vector demonstrated the same principle as observed in the asbestos-exposed mice, i.e., that the 129 mouse strain exhibits an early, protected phenotype in a proportion of the mice. We had shown previously (26) that increasing concentrations of the viral vector transduce concomitant increases in the amount of TGF-␤ 1 released in C57 mice. We used this principle here, showing that at three concentrations of virus (5 ϫ 10 7 , 10 8 , and 10 9 pfu), the 129 mice had a significantly lower mean histopathology score, and a number of individual animals exhibited no disease at 4 and 7 d after exposure ( Figure 5 ). The fact that disease severity was reversed at 14 d in this model is unexplained at this time. However, this finding suggests that temporal factors may be involved in the observed "resistance to fibrogenesis." There also is the possi- of the C57 mice early after treatment, and that is what was analysis of lung tissue from wild-type 129, C57 BL/6, and 129 ␣v ␤6 integrin knockout (KO) mice. There were clusters of genes that responded to bleomycin-induced lung injury in both the 129 and C57 strains, but these were minimally induced in the KO mice. It was fascinating to learn that the two 129 strains exhibited a delay in the proliferative response (32), even though the initial injury was similar, and all the animals eventually showed recovery of the injured airway epithelium. This is not unlike what we have reported here in two different models of lung injury. In the asbestos model, there is identical deposition of fibers (19) , but there is reduced expression of the growth factors TGF-␤ and TNF-␣ (8, 9, 19) . The mean reduction in lesion development reported in our earlier studies (19) , probably was due to the reduced response to asbestos injury exhibited by a few individual animals in the 129 strain. These individuals can be more readily identified in the data shown here (Figure 2) where 26% of the F1 ϫ 129 backcross mice exhibited no response to asbestos exposure. In the AdVTGF-␤ 1 model, there was a clear delay in the response of the 129 mice to TGF-␤ overexpression ( Figure 5 ). At 4 d after exposure, the C57 mice produced more TGF-␤ 1 , and at 7 d, many of the investigators showed a correlation between the occurrence of a polymorphism for IL-1␣ and sarcoidosis, thus demonstrating the potential of such an approach. This concept of looking for gene polymorphisms and susceptibility of endogenous latent TGF-␤ 1 by the mice, as shown here genes is becoming more prominent in the literature (34-36). (Figure 7 ) and in previous work (4, 26) . It is not difficult If TGF-␤, TNF-␣, or other growth factors are central to to envision the following: (i ) rapid transduction of active the development of IPF, correlations with genes or related TGF-␤ 1 within the first few days after treatment with the clusters could offer a key to understanding the mechanisms virus ( Figure 7 ) (4, 26); (ii) activation of genes that code involved. It will be essential for us to determine whether for latent TGF-␤ 1 and additional cytokines (4, 19, 26) ; (iii) or not similar gene arrays are found in 129 mice which fail recruitment of inflammatory cells and upregulation of mato develop inflammation and fibrosis, i.e., those mice which trix genes (Figure 8) (4, 19, 26) ; (iv) a delay or lack of are backcrossed and protected from asbestos ( Figure 2 ) or activation of certain of these key genes (or lack of recognithose wild-type 129 mice that fail to develop TGF-␤ 1 -tion of the TGF-␤ 1 signal, inactive or reduced receptor levels induced IPF ( Figure 5 ). of TGF-␤ 1 ) in some individual animals of the 129 strain;
In conclusion, in the 129 mouse strain used in our studies and (v ) failure to activate the latent TGF-␤ 1 in those animals which do not develop disease. The first three points presented here, it appears that a gene or gene cluster segrehave a great deal of support here and in the literature; the gates sufficiently to control a degree of susceptibility to last two are hypothetical and should be tested as interesting asbestos disease in some of the animals. Whether or not possibilities for explaining the differences in disease develthis is the same genetic influence that reduces the initial opment. In preliminary experiments performed with unresponse to TGF-␤ expression in some of the inbred 129 treated C57 and 129 mice, the constitutive expression of mice is not known at this time. The gene and its products TGF-␤ 1 receptors I and II and TNF-␣ receptors p55 and remain unknown, but should be identified and could offer p75 appeared to be equal as measured by RNase protection important new targets for therapy. assay of total lung RNA (personal observations). 
